CONTACT US   |  (864) 397-5101

XtremedX, LLC launches Temperature and Pressure Sensing Insole to detect diabetic foot problems early

XtremedX, LLC, a medical device technology and product innovation company based in Greenville, SC has introduced the Temperature and Pressure (TAP) Sensing Insole, the newest addition to its product line.

The Temperature and Pressure (TAP) Sensing Insole provides early detection of diabetic foot ulcerations (DFU) by incorporating flexible sensors in the shoe insoles of a diabetic patient experiencing peripheral neuropathy.

Real-time alerts are then sent to the patient, caregiver and physician, providing an earlier warning of issues and potentially preventing an infection that could result in amputation or an extended hospital stay.

The Temperature and Pressure (TAP) Sensing Insole recently received top honors in the Innovation Challenge at WearRAcon 22, the annual international conference of the Wearable Robotics Association, which was held in Scottsdale, AZ. 

In addition, the TAP Insole has been chosen as a Top 20 New Device for diabetes treatment by the Diabetes Centre Berne of Berne, Switzerland.  Only two entries from the U.S. were selected for consideration in the competition, with top honors to be bestowed in mid-May.

XtremedX was selected as a 2021 Top BIOMECHANIC Solution Provider by Med Tech Outlook magazine.  The company, which has two laboratory technology centers in Greenville where it develops products and prototypes, has research relationships with Clemson University, the University of South Carolina, and Duke University.  The organization is preparing to expand into a new 50,000 sq. ft. facility in Greenville to provide room to accelerate manufacture of the insoles and other products.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.